Companion Animal Diagnostics Market Growth & Forecast 2031

Companion Animal Diagnostics Market Growth & Forecast 2031

Segments - Companion Animal Diagnostics Market by Animal Type (Dogs, Cats, Horses, and Others), End-user (Veterinary Hospitals & Clinics, Diagnostics Labs, Point of Care, and Research Institutes & Universities), Technology (Immunodiagnostics [Immunoassay Analyzers, Lateral Flow Assays, and ELISA], Clinical Biochemistry, Hematology, Urinalysis, Molecular Diagnostics [Microarrays, and PCR], and Others), Application (Clinical Pathology, Virology, Bacteriology, Parasitology, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 - 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-4821 | 4.7 Rating | 70 Reviews | 187 Pages | Format : PDF Excel PPT

Report Description


Companion Animal Diagnostics Market Outlook 2031:

The global companion animal diagnostics market size was valued at USD 3.21 Billion in 2022 and is projected to reach USD 6.63 Billion by 2031, expanding at a CAGR of 8.4% during the forecast period 2023 - 2031The growth of the market is attributed to the increasing adoption of companion animals and the rising demand for effective diagnostics of chronic diseases in pets.

Companion animal diagnostics is the method and process followed to diagnose chronic diseases in pet animals. Molecular-level disease diagnostics in animals is possible using advanced technology and improved methodology these days.

Along with the rising healthy animal and pet food demand, the demand for effective animal diagnosis is expected to grow rapidly owing to the rising pet adoption in emerging economies.

Companion Animal Diagnostics Market Outlook

Companion animal adoption is all-time high globally, owing to the comfort and emotional support they provide with their presence in human lives. Globally, there are several types of animal species that are adopted for companionship but in most households, cats, and dogs are adopted as pets. Pets are considered family members and the importance given to their well-being and health is rising across the world.

For identifying and characterizing chronic diseases in pets, the companion animals’ diagnostic methods are considered as the best process to follow. Clinical biochemistry, immunodiagnostics, molecular diagnostics, and uranalysis are some of the diagnostics methods followed in identifying various chronic diseases in companion animals.

COVID-19 Impact

The COVID-19 pandemic’s impact on the global companion animal diagnostics market was positive, owing to the rising pet adoption across the world and the growing demand for improved diagnostics procedures. The social distancing regulations during the pandemic lockdown gave rise to loneliness and mental stress in individuals, as a companion, many adopted companion animals such as cats and dogs.

Additionally, families with pets were concerned with their pet’s health during the rise of the pandemic, which increased demand for diagnostic devices and procedures to accurately diagnose and treat diseases in pets. COVID-19 infection was also found in animals, owing to which many pet owners were alarmed. The first confirmed COVID-19 infection case in a pet dog was reported in New York by the United States agriculture department (USDA) and national veterinary services laboratories (NVSL) in June 2020.

Similarly, the first SARS-Cov-2 infection in two pet cats was found in April 2020. Various veterinary organizations came up with assays and kits to detect COVID-19 infection in companion animals. Several key players in the global market launched research and development efforts to better diagnose and treat COVID-19 infection in pets.

One of the key players in the market, IDEXX, introduced the IDEXX SARS-CoV-2 RealPCR test for companion animals. As per the study by the national center for biotechnology information (NCBI) about 40% of animals showed positive results for COVID-19 infection. The increasing COVID-19 infection concerns in pets surged demands for effective diagnostic procedures for the animals, due to which the market witnessed significant growth during the pandemic.

The rising pet ownership and demand for protecting pets from chronic diseases since the COVID-19 time is expected to drive considerable market growth in the coming years.

Companion Animal Diagnostics Market Dynamics

The research report presents a complete overview by providing detailed information about the current market trends, existing drivers, growth opportunities and potentials, and emerging challenges.

The global companion animal diagnostics market report has up-to-date insights about market dynamics and market scenarios that can shape the overall market performance and output during the forecast period, 2023 to 2031.

Global Companion Animal Diagnostics Market Dynamics

Major Trends:

Rising pet ownership across the globe

Across the globe, there is a growing trend of owning pets for companionship purposes. The adoption of pets is rising especially in families from emerging economies. According to the research published by Statista, the pet dog population in Europe grew from 89.8 million in 2020 to 92.95 million in 2021. The research platform reported that the overall number of families owning pets in Europe was around 90 million in 2021.

Similarly, the pet population in China was reported to be 190 million in 2020 and is forecasted to exceed 200 million in 2021. In developed countries, such as the US and European nations, the trend of aged people adopting pets for companionship grew significantly. The growing use of pets in social media content, ad campaigns, and movies has increased the conviction of people to own a pet.

In emerging economies such as India and China, the growing disposable income and improved lifestyle among families helped the pet industry to grow significantly. Pets are considered family members, which has increased demand for paying regular attention to their well-being and health check-ups.

The rising pet population and the growing importance of their well-being across the world are significantly boosting the global companion animal diagnostics market.

Key Drivers:

The growing expenditure on companion animals’ health and insurance

Animal health awareness is rising in families across the world, owing to which the spending on pet healthcare has significantly increased. In recent years, the demand for healthy pet foods, over-the-counter medicines & supplies, veterinary products, pet insurance, and other pet care products & services is rising across the world.

The rising animal health expenditure on pet care has given rise to the number of pet owners opting for pet insurance in developed regions like North America and Europe. According to the recent data released by the North American pet health insurance association (NAPHIA), there are 4.41 million pets who were insured in the region at the end of 2021.

The pet insurance industry grew by 27.7% over the past year. The increasing pet ownership and expenditure on their health matters is expected to drive the global companion animal diagnostics market during the forecast period.

Growing demand for automation in the diagnostics test

The growing demand for performing diagnostics tests with automated or semi-automated devices is projected to further boost the global companion animal diagnostics market. Automation in pet diagnostics tests enables handling a large number of samples with higher accuracy than manual diagnostics methods.

The automation diagnostics tests are cost-effective and can cover diagnoses for several diseases. Furthermore, the use of automation devices for glucose monitoring, in vitro diagnostics devices, and imaging systems is anticipated to further propel the global market growth in the coming years.

Existing Restraints:

Rising care costs for companion animals

The growing cost of diagnostics of chronic diseases in companion animals is anticipated to restrain the global market growth during the forecast period. Moreover, pet care costs are increasing owing to the swelling expenses on their veterinary care, food, and maintenance. The average life expectancy for dogs is 10 to 13 years and for cats its 12 to 14 years. The health issues keep increasing as they grow older.

The veterinary care cost required to keep them healthy can go up from hundreds to thousands of dollars every year. Additionally, hundreds of dollars need to be paid for pet insurance every month. Although the pet insurance industry is growing, the insurance providers do not include several companion animals under the insurance schemes, owing to which the owners have to bear all the costs of diagnostics and treatments.

Pet care is a niche service area and generates low opportunities for income for professionals in the field, owing to which veterinary professionals charge higher consultations and treatment fees.

Emerging Opportunities:

Growing demand for portable instruments and rapid tests

As the companion animal population has significantly increased across the world, there is a rising demand for on-field veterinarian services in remote locations. The key players in the global companion animal diagnostics market are investing time and money in the research and development of advanced portable instruments to ease the work of field veterinarians.

The data transfer and portability features allow the portable instruments to be effective even in remote areas. On-field veterinarians using portable instruments can extend their service area as well as their productivity. Moreover, rapid diagnostics tests are also becoming one of the most preferred methods of diagnosis by end-users, owing to their specificity, low cost, and ease of use.

The growing popularity of rapid tests has made the key players in the global market bring advanced solutions to the market which can provide test results within 24 hours or even at the time of initial examination. Technological advancements and innovative devices for diagnostics are expected to create significant growth opportunities in the global companion animal diagnostics market during the forecast period.

Scope of the Companion Animal Diagnostics Market Report

The global companion animal diagnostics market research report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Companion Animal Diagnostics Market Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Animal Type (Dogs, Cats, Horses, and Others), End-user (Veterinary Hospitals & Clinics, Diagnostics Labs, Point of Care, and Research Institutes & Universities), Technology (Immunodiagnostics [Immunoassay Analyzers, Lateral Flow Assays, and ELISA], Clinical Biochemistry, Hematology, Urinalysis, Molecular Diagnostics [Microarrays, and PCR], and Others), and Application (Clinical Pathology, Virology, Bacteriology, Parasitology, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast

Key Players Covered in the Report

IDEXX; Zoetis; Bio-Rad Laboratories, Inc.; Abaxis; Heska Corporation; Thermo Fisher Scientific, INC.; BIOMÉRIEUX; FUJIFILM Holdings Corporation; Virbac; Neogen Corporation; Randox Laboratories Ltd.; Shenzhen Mindray Animal Medical Technology Co., LTD.; Bionote USA Inc.; Agrolabo S.p.A.; Creative Diagnostics; HyTest Ltd.; TriviumVet; QIAGEN; INDICAL BIOSCIENCE GmbH; and Innovative Diagnostics.

Companion Animal Diagnostics Market Segment Insights

The dogs segment projected to hold the major market share

On the basis of animal type, the global companion animal diagnostics market is categorized into dogs, cats, horses, and others. The dog segment held a majority share of the global market and is expected to continue growing at a considerable pace during the forecast period. The segment growth is attributed to the rising dog ownership across the globe for companionship purposes.

The factors which are helping the dog segment to grow further in the global market are the rising cases of obesity, cancer, diabetes, and zoonotic diseases in pet dogs. Additionally, an increasing purchase of insurance for canine pets in developed countries is also expected to aid the market growth in the coming years.


The cats segment is also expected to expand at a considerable rate in the projection period, owing to the rising cat adoption in families across the world. Diseases such as allergies, diarrhea, eye problems, tapeworms, and fleas are common in cats.

The growing cat population is expected to drive the demand for rapid diagnostics solutions, helping the segment grow significantly during the forecast period.

Companion Animal Diagnostics Market Animal Type

Diagnostics Labs segment to expand at a considerable rate

Based on the end-user, the global market is divided into veterinary hospitals & clinics, diagnostics labs, point of care, and research institutes & universities. The diagnostics labs segment held the major share of the global market in 2021 and is projected to expand at a considerable rate in the coming years.

The segment growth is owing to the rising number of samples received by the diagnostics labs for analysis from veterinary care providers, researchers, and private & government organizations.

The diagnostics labs provide testing solutions for various diseases, infections, and toxic agent samples. Pet owners, vets, researchers, and others are some of the key customers for the diagnostics labs.


The point of care segment is also anticipated to expand at a considerable CAGR during the forecast period, owing to the rising number of pet owners opting for PoC testing for diagnostics purposes. Veterinary PoC diagnostics devices provide significant information on pet diseases without relying on the results from clinical labs. PoC providers offer diverse testing options and quality results in a limited time, which is expected to help the segment grow substantially in the coming years.

Clinical Biochemistry segment to expand at a significant CAGR

In terms of technology, the global companion animal diagnostics market is segmented into immunodiagnostics, clinical biochemistry, hematology, urinalysis, molecular diagnostics, and others.

The immunodiagnostics segment is further divided into immunoassay analyzers, lateral flow assays, and ELISA. Additionally, the molecular diagnostics segment is further bifurcated into microarrays and PCR.

The clinical biochemistry segment is anticipated to expand a significant CAGR during the projection period, due to the increasing number of companion animal owners opting for clinical biochemistry tests for initial diagnostics of several illnesses. Clinical biochemistry technology can help in evaluating diseases and disorders in pets such as diabetes, blood gas electrolytes analysis, kidney disorders, and liver disorders among others.


The molecular diagnostics technology segment is projected to showcase the second-fastest growth in the global companion animal diagnostics market. The molecular diagnostics field is rapidly evolving in the veterinary space.

Molecular diagnosis technology offers an array of procedures with different complexities to provide a quick and specific diagnosis of animal diseases. DNA, mass spectrometry, and genetic assays are the common molecular diagnostics tests available in the global market.

Clinical Pathology segment to grow at a substantial pace

Based on the application, the global companion animal diagnostics market is divided into clinical pathology, virology, bacteriology, parasitology, and others. Clinical pathology segment held the largest share of the market in terms of application and is projected to grow at a substantial pace during the forecast period.

Clinical pathology helps in diagnosing diseases in animals through blood, fluids, and tissue examination. Growing chronic diseases such as skin diseases, rabies virus infections, and others are the major factors in boosting segment growth in the global market.


Bacteriology segment is expected to grow second fastest in the global market due to rising bacterial infections in companion animals such as cats and dogs. The key focus of bacteriology is to assist vets and animal owners in diagnosing and identifying the causes of bacteria and fungi infections in animals.

The diagnosis test is performed on blood, stool, urine, skin, and spinal fluid samples. The rising demand to keep companion animals bacteria infection free is driving the global market growth.

Companion Animal Diagnostics Market Application

North America to dominate the global market

In terms of region, the global companion animal diagnostics market is categorized into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is projected to dominate the global market, owing to the rising companion animal ownership in the region. According to a study published by Statista, about 70% of households own one or more pets in 2020.

According to the survey, 63 million households in the US had dogs as pet animals, making dogs the most preferred companion animal in the region. Cats and fish ownership ranked second and third place, and about 1.6 million households owned horses in the United States.

Moreover, due to the rising pet population in the region, several key players in the market are focused on providing innovative diagnostics solutions to animal owners and vets to keep companion animals healthy.


Asia Pacific region is projected to see the second largest growth in the global market owing to the increased popularity to adopt pet animals in households. The improved lifestyle and growing disposable income in families allow them to adopt one or more pet animals as a companion. The growth in the pet animal population is helping the boost demand for better companion animal diagnostics solutions from vets as well as animal owners. Increased demand for innovative animal diagnostics solutions is expected to drive market growth in the region during the forecast period.

Companion Animal Diagnostics Market Region

Segments

The global companion animal diagnostics market has been segmented on the basis of

Animal Type

  • Dogs
  • Cats
  • Horses
  • Others

End-user

  • Veterinary Hospitals & Clinics
  • Diagnostics Labs
  • Point of Care
  • Research Institutes & Universities

Technology

  • Immunodiagnostics
    • Immunoassay Analyzers
    • Lateral Flow Assays
    • ELISA
  • Clinical Biochemistry
  • Hematology
  • Urinalysis
  • Molecular Diagnostics
    • Microarrays
    • PCR
  • Others

Application

  • Clinical Pathology
  • Virology
  • Bacteriology
  • Parasitology
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • IDEXX
  • Zoetis
  • Bio-Rad Laboratories, Inc.
  • Abaxis
  • Heska Corporation
  • Thermo Fisher Scientific, INC.
  • BIOMÉRIEUX
  • FUJIFILM Holdings Corporation
  • Virbac
  • Neogen Corporation
  • Randox Laboratories Ltd.
  • Shenzhen Mindray Animal Medical Technology Co., LTD.
  • Bionote USA Inc.
  • Agrolabo S.p.A.
  • Creative Diagnostics
  • HyTest Ltd.
  • TriviumVet
  • QIAGEN
  • INDICAL BIOSCIENCE GmbH
  • Innovative Diagnostics

Competitive Landscape

Key players competing in the global companion animal diagnostics market are IDEXX; Zoetis; Bio-Rad Laboratories, Inc.; Abaxis; Heska Corporation; Thermo Fisher Scientific, INC.; BIOMÉRIEUX; FUJIFILM Holdings Corporation; Virbac; Neogen Corporation; Randox Laboratories Ltd.; Shenzhen Mindray Animal Medical Technology Co., LTD.; Bionote USA Inc.; Agrolabo S.p.A.; Creative Diagnostics; HyTest Ltd.; TriviumVet; QIAGEN; INDICAL BIOSCIENCE GmbH; and Innovative Diagnostics.

Some of these major companies have adopted various business development strategies including acquisitions, mergers, collaborations, partnerships, product launches, and production capacity expansion to expand their consumer base and enhance their market share.

  • On 13th October 2022, Randox Laboratories Ltd., a leading diagnostics solutions and services provider company from the United Kingdom announced a collaboration with Verv Technologies to improve health for all. Randox has 40 years of experience in providing diagnostics solutions and is aiming to invest more in technologies to provide improved health solutions.
  • On 13th January 2022, IDEXX Laboratories a globally leading pet animal healthcare innovative solution provider announce the expansion of its laboratory tests and services. The expansion is in the Oncology tests offering. which is aimed to help vets better diagnose and treat cancer in companion animals. IDEXX is focused on enhancing the lives of pets by building on its cancer pathology expertise, to provide vets with a comprehensive cancer diagnosis and support solutions.
Companion Animal Diagnostics Market Key Players

Frequently Asked Questions

The market is estimated to register a CAGR of around 8.4% during the forecast period.

The global companion animal diagnostics market size was valued at around USD 2.96 billion in 2021 and is anticipated to reach around USD 6.86 billion by 2030.

Clinical pathology segment held the largest share of the market in terms of application and is projected to grow at a substantial pace during the forecast period.

North America is projected to dominate the global companion animal diagnostics market during the forecast period.

IDEXX; Zoetis; Bio-Rad Laboratories, Inc.; Abaxis; Heska Corporation; Thermo Fisher Scientific, INC., and BIOMÉRIEUX are the key players in the global market.

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Companion Animal Diagnostics Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Companion Animal Diagnostics Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Companion Animal Diagnostics Market - Supply Chain
  4.5. Global Companion Animal Diagnostics Market Forecast
     4.5.1. Companion Animal Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Companion Animal Diagnostics Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Companion Animal Diagnostics Market Absolute $ Opportunity
5. Global Companion Animal Diagnostics Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Companion Animal Diagnostics Market Size and Volume Forecast by Applications
     5.3.1. Clinical Pathology
     5.3.2. Virology
     5.3.3. Bacteriology
     5.3.4. Parasitology
     5.3.5. Others
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Companion Animal Diagnostics Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Companion Animal Diagnostics Market Size and Volume Forecast by End Users
     6.3.1. Veterinary Hospitals & Clinics
     6.3.2. Diagnostics Labs
     6.3.3. Point of Care
     6.3.4. Research Institutes & Universities
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Companion Animal Diagnostics Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Companion Animal Diagnostics Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Companion Animal Diagnostics Demand Share Forecast, 2019-2026
8. North America Companion Animal Diagnostics Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Companion Animal Diagnostics Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Companion Animal Diagnostics Market Size and Volume Forecast by Applications
     8.4.1. Clinical Pathology
     8.4.2. Virology
     8.4.3. Bacteriology
     8.4.4. Parasitology
     8.4.5. Others
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. North America Companion Animal Diagnostics Market Size and Volume Forecast by End Users
     8.7.1. Veterinary Hospitals & Clinics
     8.7.2. Diagnostics Labs
     8.7.3. Point of Care
     8.7.4. Research Institutes & Universities
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Companion Animal Diagnostics Demand Share Forecast, 2019-2026
9. Latin America Companion Animal Diagnostics Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Companion Animal Diagnostics Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Companion Animal Diagnostics Market Size and Volume Forecast by Applications
     9.4.1. Clinical Pathology
     9.4.2. Virology
     9.4.3. Bacteriology
     9.4.4. Parasitology
     9.4.5. Others
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Latin America Companion Animal Diagnostics Market Size and Volume Forecast by End Users
     9.7.1. Veterinary Hospitals & Clinics
     9.7.2. Diagnostics Labs
     9.7.3. Point of Care
     9.7.4. Research Institutes & Universities
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Companion Animal Diagnostics Demand Share Forecast, 2019-2026
10. Europe Companion Animal Diagnostics Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Companion Animal Diagnostics Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Companion Animal Diagnostics Market Size and Volume Forecast by Applications
     10.4.1. Clinical Pathology
     10.4.2. Virology
     10.4.3. Bacteriology
     10.4.4. Parasitology
     10.4.5. Others
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Europe Companion Animal Diagnostics Market Size and Volume Forecast by End Users
     10.7.1. Veterinary Hospitals & Clinics
     10.7.2. Diagnostics Labs
     10.7.3. Point of Care
     10.7.4. Research Institutes & Universities
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Companion Animal Diagnostics Demand Share Forecast, 2019-2026
11. Asia Pacific Companion Animal Diagnostics Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Companion Animal Diagnostics Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Companion Animal Diagnostics Market Size and Volume Forecast by Applications
     11.4.1. Clinical Pathology
     11.4.2. Virology
     11.4.3. Bacteriology
     11.4.4. Parasitology
     11.4.5. Others
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Asia Pacific Companion Animal Diagnostics Market Size and Volume Forecast by End Users
     11.7.1. Veterinary Hospitals & Clinics
     11.7.2. Diagnostics Labs
     11.7.3. Point of Care
     11.7.4. Research Institutes & Universities
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Companion Animal Diagnostics Demand Share Forecast, 2019-2026
12. Middle East & Africa Companion Animal Diagnostics Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Companion Animal Diagnostics Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Companion Animal Diagnostics Market Size and Volume Forecast by Applications
     12.4.1. Clinical Pathology
     12.4.2. Virology
     12.4.3. Bacteriology
     12.4.4. Parasitology
     12.4.5. Others
  12.5. Basis Point Share (BPS) Analysis by Applications
  12.6. Y-o-Y Growth Projections by Applications
  12.7. Middle East & Africa Companion Animal Diagnostics Market Size and Volume Forecast by End Users
     12.7.1. Veterinary Hospitals & Clinics
     12.7.2. Diagnostics Labs
     12.7.3. Point of Care
     12.7.4. Research Institutes & Universities
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Companion Animal Diagnostics Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Companion Animal Diagnostics Market: Market Share Analysis
  13.2. Companion Animal Diagnostics Distributors and Customers
  13.3. Companion Animal Diagnostics Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. IDEXX
     13.4.2. Zoetis
     13.4.3. Bio-Rad Laboratories, Inc.
     13.4.4. Abaxis
     13.4.5. Heska Corporation
     13.4.6. Thermo Fisher Scientific, INC.
     13.4.7. BIOMÉRIEUX
     13.4.8. FUJIFILM Holdings Corporation
     13.4.9. Virbac
     13.4.10. Neogen Corporation
     13.4.11. Randox Laboratories Ltd.
     13.4.12. Shenzhen Mindray Animal Medical Technology Co., LTD.
     13.4.13. Bionote USA Inc.
     13.4.14. Agrolabo S.p.A.
     13.4.15. Creative Diagnostics
     13.4.16. HyTest Ltd.
     13.4.17. TriviumVet
     13.4.18. QIAGEN
     13.4.19. INDICAL BIOSCIENCE GmbH
     13.4.20. Innovative Diagnostic

Methodology

Our Clients

Honda Motor Co. Ltd.
Dassault Aviation
FedEx Logistics
Deloitte
Microsoft
sinopec
Nestle SA
General Mills